Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.33 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.33 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.32 |
| ▸ | RAC2 | P15153 | 1/20 | 0.32 |
| ▸ | RAC3 | P60763 | 1/20 | 0.32 |
| ▸ | CDC42 | P60953 | 1/20 | 0.32 |
| ▸ | RAC1 | P63000 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16978856 | 1.00 | KDM4E (0.47) | KDM4EATML3MBTL1PTPN1MAPK8 | |
| SCHEMBL16978841 | 0.95 | KDM4E (0.47) | KDM4EATML3MBTL1PTPN1MAPK8 | |
| SCHEMBL16978850 | 0.95 | L3MBTL1 (0.49) | KDM4EATML3MBTL1PTPN1MAPK8 | |
| SCHEMBL17448911 | 0.93 | L3MBTL1 (0.45) | KDM4EATML3MBTL1MAPK8MAPK9 | |
| SCHEMBL16977101 | 0.93 | KDM4E (0.45) | KDM4EATML3MBTL1MAPK8MAPK9 | |
| SCHEMBL16977040 | 0.93 | L3MBTL1 (0.49) | KDM4EATML3MBTL1PTPN1MAPK8 | |
| SCHEMBL16977052 | 0.93 | KDM4E (0.43) | KDM4EATML3MBTL1MAPK8 | |
| SCHEMBL17448881 | 0.92 | KDM4E (0.45) | KDM4EATML3MBTL1PTPN1MAPK8 | |
| SCHEMBL16978886 | 0.91 | KDM4E (0.41) | KDM4EATML3MBTL1MAPK8KMT2A | |
| SCHEMBL17448902 | 0.91 | L3MBTL1 (0.47) | KDM4EATML3MBTL1PTPN1MAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150218191-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2015-08-06 | — | — | US | disclosed |
| US-20150218191-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2015-08-06 | — | — | US | disclosed |
| EP-2903048-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | Nippon Steel & Sumikin Chemical Co., Ltd. (JP) | 2015-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150218191-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | EBPL, ELOC, EML4 | KDM4E 1194/4885ATM 4343/4885L3MBTL1 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.